Search results
MBX Biosciences seeks up to $482.5 mln valuation in US IPO
Reuters· 2 days agoMBX Biosciences, which is developing peptide therapies for treating endocrine and metabolic...
MBX Biosciences, which is developing peptide therapies for treating endocrine and metabolic...